Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies

BACKGROUND: Programmed death protein (PD)-1 blockade immunotherapy significantly prolongs survival in patients with metastatic mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal malignancies such gastric and colorectal cancer. However, the data on preoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying-Jie, Liu, Xin-Zhi, Yao, Yun-Feng, Chen, Nan, Li, Zhong-Wu, Zhang, Xiao-Yan, Lin, Xin-Feng, Wu, Ai-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988634/
https://www.ncbi.nlm.nih.gov/pubmed/36896306
http://dx.doi.org/10.4240/wjgs.v15.i2.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988634/
https://www.ncbi.nlm.nih.gov/pubmed/36896306
http://dx.doi.org/10.4240/wjgs.v15.i2.222

Ejemplares similares